Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO9686 | Lonchocarpus neuroscapha | Species | Fabaceae | Eukaryota |
PMID[21158427] |
|||
NPO4615 | Prosopis alba | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO2314 | Endiandra palmerstonii | Species | Lauraceae | Eukaryota | UNPD* | |||
NPO26305 | Zanthoxylum rhetsum | Species | Rutaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT314 | Organism | Bacillus cereus | Bacillus cereus | MIC | = | 1000 | ug/ml | 18951808 |
NPT314 | Organism | Bacillus cereus | Bacillus cereus | MBC | = | 1000 | ug/ml | 18951808 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 2000 | ug/ml | 18951808 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MBC | > | 2000 | ug/ml | 18951808 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 2000 | ug/ml | 18951808 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MBC | = | 2000 | ug/ml | 18951808 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2000 | ug/ml | 18951808 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MBC | = | 2000 | ug/ml | 18951808 |
NPT2 | Others | Unspecified | MIC | = | 5 | ug/ml | 21158427 | |
NPT1484 | Organism | Fusobacterium nucleatum | Fusobacterium nucleatum | MIC | = | 40 | ug/ml | 21158427 |
NPT1128 | Organism | Prevotella intermedia | Prevotella intermedia | MIC | = | 2.5 | ug/ml | 21158427 |
NPT2 | Others | Unspecified | MBC | = | 10 | ug/ml | 21158427 | |
NPT1484 | Organism | Fusobacterium nucleatum | Fusobacterium nucleatum | MBC | > | 40 | ug/ml | 21158427 |
NPT1128 | Organism | Prevotella intermedia | Prevotella intermedia | MBC | = | 5 | ug/ml | 21158427 |
NPT1128 | Organism | Prevotella intermedia | Prevotella intermedia | Activity | = | 45 | % | 21158427 |
NPT2 | Others | Unspecified | Inhibition | = | 31 | % | 21158427 | |
NPT2 | Others | Unspecified | Inhibition | = | 36 | % | 21158427 | |
NPT466 | Cell Line | U-937 | Homo sapiens | Inhibition | = | 29 | % | 21158427 |
NPT466 | Cell Line | U-937 | Homo sapiens | Inhibition | = | 38 | % | 21158427 |
NPT466 | Cell Line | U-937 | Homo sapiens | Inhibition | = | 23 | % | 21158427 |
NPT466 | Cell Line | U-937 | Homo sapiens | Inhibition | = | 50 | % | 21158427 |
NPT466 | Cell Line | U-937 | Homo sapiens | Inhibition | = | 67 | % | 21158427 |
NPT2 | Others | Unspecified | IC50 | = | 87000 | nM | 21696954 | |
NPT2 | Others | Unspecified | IC50 | = | 58000 | nM | 21696954 | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 66000 | nM | 21696954 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | > | 100000 | nM | 21696954 |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | IC50 | > | 100000 | nM | 21696954 |
NPT114 | Cell Line | LoVo | Homo sapiens | IC50 | = | 57000 | nM | 21696954 |
NPT2 | Others | Unspecified | GI | = | 70 | % | 21696954 | |
NPT2 | Others | Unspecified | Activity | = | 17 | % | 21696954 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 0.712 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 0.757 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 0.822 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 0.877 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 1.269 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 1.929 | 22472691 | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 4.827 | 22472691 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC188879 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9924 | High Similarity | NPC240593 |
0.9924 | High Similarity | NPC124269 |
0.9774 | High Similarity | NPC99333 |
0.9774 | High Similarity | NPC280284 |
0.9774 | High Similarity | NPC188947 |
0.9699 | High Similarity | NPC275055 |
0.9699 | High Similarity | NPC266597 |
0.9699 | High Similarity | NPC290291 |
0.9699 | High Similarity | NPC250266 |
0.9695 | High Similarity | NPC192304 |
0.9695 | High Similarity | NPC312318 |
0.9695 | High Similarity | NPC263670 |
0.9695 | High Similarity | NPC472365 |
0.9695 | High Similarity | NPC175098 |
0.9695 | High Similarity | NPC337373 |
0.9695 | High Similarity | NPC188646 |
0.9695 | High Similarity | NPC242294 |
0.9695 | High Similarity | NPC56031 |
0.9695 | High Similarity | NPC139813 |
0.963 | High Similarity | NPC6407 |
0.963 | High Similarity | NPC284550 |
0.963 | High Similarity | NPC76445 |
0.963 | High Similarity | NPC129853 |
0.963 | High Similarity | NPC110228 |
0.963 | High Similarity | NPC188243 |
0.9624 | High Similarity | NPC13408 |
0.9624 | High Similarity | NPC124784 |
0.9624 | High Similarity | NPC29353 |
0.9624 | High Similarity | NPC473887 |
0.9624 | High Similarity | NPC194281 |
0.9624 | High Similarity | NPC234133 |
0.9624 | High Similarity | NPC47815 |
0.9624 | High Similarity | NPC231772 |
0.9624 | High Similarity | NPC127447 |
0.9621 | High Similarity | NPC286336 |
0.9618 | High Similarity | NPC212631 |
0.9618 | High Similarity | NPC203817 |
0.9618 | High Similarity | NPC257756 |
0.9618 | High Similarity | NPC129132 |
0.9618 | High Similarity | NPC205468 |
0.9618 | High Similarity | NPC87231 |
0.9562 | High Similarity | NPC143896 |
0.9562 | High Similarity | NPC221432 |
0.9562 | High Similarity | NPC164980 |
0.9562 | High Similarity | NPC75049 |
0.9562 | High Similarity | NPC149026 |
0.9562 | High Similarity | NPC310130 |
0.9562 | High Similarity | NPC169591 |
0.9562 | High Similarity | NPC68104 |
0.9562 | High Similarity | NPC39329 |
0.9562 | High Similarity | NPC91560 |
0.9562 | High Similarity | NPC175504 |
0.9562 | High Similarity | NPC257097 |
0.9562 | High Similarity | NPC150408 |
0.9559 | High Similarity | NPC110969 |
0.9559 | High Similarity | NPC3188 |
0.9556 | High Similarity | NPC20709 |
0.9556 | High Similarity | NPC225153 |
0.9556 | High Similarity | NPC140890 |
0.9556 | High Similarity | NPC310135 |
0.9556 | High Similarity | NPC261234 |
0.9556 | High Similarity | NPC222342 |
0.9556 | High Similarity | NPC329203 |
0.9556 | High Similarity | NPC150648 |
0.9556 | High Similarity | NPC265871 |
0.9556 | High Similarity | NPC274784 |
0.9545 | High Similarity | NPC18877 |
0.9545 | High Similarity | NPC82225 |
0.9545 | High Similarity | NPC294593 |
0.9545 | High Similarity | NPC159623 |
0.9545 | High Similarity | NPC204960 |
0.9545 | High Similarity | NPC20560 |
0.9545 | High Similarity | NPC144051 |
0.9545 | High Similarity | NPC28753 |
0.9542 | High Similarity | NPC262359 |
0.9542 | High Similarity | NPC308037 |
0.9542 | High Similarity | NPC64359 |
0.9493 | High Similarity | NPC236766 |
0.9493 | High Similarity | NPC473015 |
0.9493 | High Similarity | NPC209040 |
0.9493 | High Similarity | NPC473013 |
0.9493 | High Similarity | NPC197252 |
0.9489 | High Similarity | NPC1089 |
0.9489 | High Similarity | NPC125855 |
0.9489 | High Similarity | NPC182852 |
0.9489 | High Similarity | NPC107572 |
0.9489 | High Similarity | NPC324134 |
0.9489 | High Similarity | NPC306829 |
0.9489 | High Similarity | NPC11561 |
0.9489 | High Similarity | NPC32739 |
0.9489 | High Similarity | NPC161506 |
0.9489 | High Similarity | NPC226636 |
0.9489 | High Similarity | NPC37496 |
0.9489 | High Similarity | NPC76372 |
0.9489 | High Similarity | NPC167624 |
0.9489 | High Similarity | NPC220998 |
0.9489 | High Similarity | NPC76338 |
0.9489 | High Similarity | NPC227579 |
0.9489 | High Similarity | NPC78 |
0.9489 | High Similarity | NPC324436 |
0.9489 | High Similarity | NPC166482 |
0.9489 | High Similarity | NPC194432 |
0.9489 | High Similarity | NPC223500 |
0.9489 | High Similarity | NPC328164 |
0.9489 | High Similarity | NPC10937 |
0.9489 | High Similarity | NPC265040 |
0.9489 | High Similarity | NPC177354 |
0.9489 | High Similarity | NPC166934 |
0.9489 | High Similarity | NPC228504 |
0.9489 | High Similarity | NPC296917 |
0.9489 | High Similarity | NPC148757 |
0.9489 | High Similarity | NPC66515 |
0.9489 | High Similarity | NPC40833 |
0.9489 | High Similarity | NPC202981 |
0.9489 | High Similarity | NPC64915 |
0.9485 | High Similarity | NPC270883 |
0.9485 | High Similarity | NPC269652 |
0.9485 | High Similarity | NPC261227 |
0.9485 | High Similarity | NPC241100 |
0.9485 | High Similarity | NPC69769 |
0.9485 | High Similarity | NPC159275 |
0.9485 | High Similarity | NPC281207 |
0.9485 | High Similarity | NPC172986 |
0.9481 | High Similarity | NPC147686 |
0.9481 | High Similarity | NPC472460 |
0.9481 | High Similarity | NPC329225 |
0.9481 | High Similarity | NPC118813 |
0.9478 | High Similarity | NPC186838 |
0.9478 | High Similarity | NPC477243 |
0.9478 | High Similarity | NPC187826 |
0.9478 | High Similarity | NPC473391 |
0.9478 | High Similarity | NPC66349 |
0.9478 | High Similarity | NPC472367 |
0.9478 | High Similarity | NPC98115 |
0.9478 | High Similarity | NPC472364 |
0.9478 | High Similarity | NPC168105 |
0.9478 | High Similarity | NPC477242 |
0.9478 | High Similarity | NPC477244 |
0.9478 | High Similarity | NPC476333 |
0.9478 | High Similarity | NPC274109 |
0.9478 | High Similarity | NPC1486 |
0.9478 | High Similarity | NPC41461 |
0.9478 | High Similarity | NPC25287 |
0.9478 | High Similarity | NPC249606 |
0.9478 | High Similarity | NPC150399 |
0.9478 | High Similarity | NPC12165 |
0.9474 | High Similarity | NPC144027 |
0.9474 | High Similarity | NPC125269 |
0.9474 | High Similarity | NPC172262 |
0.9474 | High Similarity | NPC236974 |
0.947 | High Similarity | NPC10971 |
0.9424 | High Similarity | NPC299011 |
0.9424 | High Similarity | NPC130176 |
0.9424 | High Similarity | NPC99454 |
0.942 | High Similarity | NPC316816 |
0.942 | High Similarity | NPC81697 |
0.942 | High Similarity | NPC107177 |
0.942 | High Similarity | NPC106985 |
0.942 | High Similarity | NPC223812 |
0.942 | High Similarity | NPC125894 |
0.942 | High Similarity | NPC278249 |
0.942 | High Similarity | NPC214166 |
0.942 | High Similarity | NPC77794 |
0.942 | High Similarity | NPC185276 |
0.942 | High Similarity | NPC85162 |
0.942 | High Similarity | NPC478086 |
0.942 | High Similarity | NPC166138 |
0.942 | High Similarity | NPC18585 |
0.9416 | High Similarity | NPC324386 |
0.9416 | High Similarity | NPC282300 |
0.9416 | High Similarity | NPC90582 |
0.9416 | High Similarity | NPC262094 |
0.9416 | High Similarity | NPC96408 |
0.9416 | High Similarity | NPC279650 |
0.9416 | High Similarity | NPC248372 |
0.9416 | High Similarity | NPC166689 |
0.9416 | High Similarity | NPC258630 |
0.9416 | High Similarity | NPC312391 |
0.9416 | High Similarity | NPC110038 |
0.9416 | High Similarity | NPC205006 |
0.9416 | High Similarity | NPC103362 |
0.9416 | High Similarity | NPC147688 |
0.9416 | High Similarity | NPC17170 |
0.9416 | High Similarity | NPC156590 |
0.9416 | High Similarity | NPC213322 |
0.9416 | High Similarity | NPC136840 |
0.9416 | High Similarity | NPC64908 |
0.9416 | High Similarity | NPC118840 |
0.9416 | High Similarity | NPC156190 |
0.9416 | High Similarity | NPC4743 |
0.9412 | High Similarity | NPC303633 |
0.9412 | High Similarity | NPC217186 |
0.9412 | High Similarity | NPC18260 |
0.9412 | High Similarity | NPC23257 |
0.9412 | High Similarity | NPC143799 |
0.9412 | High Similarity | NPC152042 |
0.9412 | High Similarity | NPC241838 |
0.9412 | High Similarity | NPC220062 |
0.9412 | High Similarity | NPC96565 |
0.9412 | High Similarity | NPC78913 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC188879 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9481 | High Similarity | NPD1549 | Phase 2 |
0.9407 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9407 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9394 | High Similarity | NPD1240 | Approved |
0.9259 | High Similarity | NPD1510 | Phase 2 |
0.9254 | High Similarity | NPD1607 | Approved |
0.9214 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9191 | High Similarity | NPD2796 | Approved |
0.9143 | High Similarity | NPD6799 | Approved |
0.9078 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8966 | High Similarity | NPD7411 | Suspended |
0.8851 | High Similarity | NPD3882 | Suspended |
0.8844 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8815 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8792 | High Similarity | NPD7075 | Discontinued |
0.8784 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8777 | High Similarity | NPD1551 | Phase 2 |
0.8776 | High Similarity | NPD1934 | Approved |
0.8767 | High Similarity | NPD4380 | Phase 2 |
0.8767 | High Similarity | NPD6599 | Discontinued |
0.8741 | High Similarity | NPD1511 | Approved |
0.8716 | High Similarity | NPD2801 | Approved |
0.8716 | High Similarity | NPD7819 | Suspended |
0.8716 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8667 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8649 | High Similarity | NPD6801 | Discontinued |
0.8621 | High Similarity | NPD1512 | Approved |
0.8592 | High Similarity | NPD7421 | Clinical (unspecified phase) |
0.8531 | High Similarity | NPD3750 | Approved |
0.8521 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8477 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8452 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8444 | Intermediate Similarity | NPD1203 | Approved |
0.8435 | Intermediate Similarity | NPD5403 | Approved |
0.8411 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8403 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8394 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8333 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8333 | Intermediate Similarity | NPD2800 | Approved |
0.8333 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8322 | Intermediate Similarity | NPD2344 | Approved |
0.8301 | Intermediate Similarity | NPD3749 | Approved |
0.8299 | Intermediate Similarity | NPD5401 | Approved |
0.8298 | Intermediate Similarity | NPD6651 | Approved |
0.8258 | Intermediate Similarity | NPD6959 | Discontinued |
0.8252 | Intermediate Similarity | NPD2935 | Discontinued |
0.8228 | Intermediate Similarity | NPD3818 | Discontinued |
0.8222 | Intermediate Similarity | NPD9717 | Approved |
0.8207 | Intermediate Similarity | NPD1243 | Approved |
0.8188 | Intermediate Similarity | NPD920 | Approved |
0.8187 | Intermediate Similarity | NPD5953 | Discontinued |
0.8182 | Intermediate Similarity | NPD2799 | Discontinued |
0.8182 | Intermediate Similarity | NPD3748 | Approved |
0.8176 | Intermediate Similarity | NPD7054 | Approved |
0.8176 | Intermediate Similarity | NPD7286 | Phase 2 |
0.8176 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8163 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.8151 | Intermediate Similarity | NPD4628 | Phase 3 |
0.8148 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.8125 | Intermediate Similarity | NPD7472 | Approved |
0.8125 | Intermediate Similarity | NPD7074 | Phase 3 |
0.812 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8117 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD2309 | Approved |
0.8077 | Intermediate Similarity | NPD5494 | Approved |
0.8075 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8054 | Intermediate Similarity | NPD2532 | Approved |
0.8054 | Intermediate Similarity | NPD2534 | Approved |
0.8054 | Intermediate Similarity | NPD2533 | Approved |
0.8054 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.8052 | Intermediate Similarity | NPD5402 | Approved |
0.8028 | Intermediate Similarity | NPD943 | Approved |
0.8025 | Intermediate Similarity | NPD7251 | Discontinued |
0.8015 | Intermediate Similarity | NPD422 | Phase 1 |
0.8 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7985 | Intermediate Similarity | NPD9545 | Approved |
0.7975 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7975 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7959 | Intermediate Similarity | NPD2654 | Approved |
0.7931 | Intermediate Similarity | NPD7033 | Discontinued |
0.7914 | Intermediate Similarity | NPD6559 | Discontinued |
0.7887 | Intermediate Similarity | NPD3268 | Approved |
0.7887 | Intermediate Similarity | NPD2313 | Discontinued |
0.7887 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7883 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7879 | Intermediate Similarity | NPD1241 | Discontinued |
0.7877 | Intermediate Similarity | NPD6099 | Approved |
0.7877 | Intermediate Similarity | NPD6100 | Approved |
0.7866 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7862 | Intermediate Similarity | NPD6232 | Discontinued |
0.7857 | Intermediate Similarity | NPD2798 | Approved |
0.7847 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7836 | Intermediate Similarity | NPD9493 | Approved |
0.7826 | Intermediate Similarity | NPD3972 | Approved |
0.7826 | Intermediate Similarity | NPD7473 | Discontinued |
0.7812 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7808 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7786 | Intermediate Similarity | NPD2797 | Approved |
0.7785 | Intermediate Similarity | NPD919 | Approved |
0.773 | Intermediate Similarity | NPD5844 | Phase 1 |
0.773 | Intermediate Similarity | NPD1019 | Discontinued |
0.7727 | Intermediate Similarity | NPD3226 | Approved |
0.7724 | Intermediate Similarity | NPD1933 | Approved |
0.7724 | Intermediate Similarity | NPD230 | Phase 1 |
0.7714 | Intermediate Similarity | NPD3225 | Approved |
0.7688 | Intermediate Similarity | NPD1247 | Approved |
0.7687 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7683 | Intermediate Similarity | NPD1729 | Discontinued |
0.7667 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7639 | Intermediate Similarity | NPD411 | Approved |
0.7636 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7603 | Intermediate Similarity | NPD447 | Suspended |
0.7597 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.759 | Intermediate Similarity | NPD6104 | Discontinued |
0.7584 | Intermediate Similarity | NPD2346 | Discontinued |
0.7571 | Intermediate Similarity | NPD1608 | Approved |
0.7535 | Intermediate Similarity | NPD3266 | Approved |
0.7535 | Intermediate Similarity | NPD3267 | Approved |
0.7534 | Intermediate Similarity | NPD3140 | Approved |
0.7534 | Intermediate Similarity | NPD3142 | Approved |
0.7532 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7529 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD6798 | Discontinued |
0.7517 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7516 | Intermediate Similarity | NPD7390 | Discontinued |
0.7516 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7514 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7514 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7484 | Intermediate Similarity | NPD4288 | Approved |
0.7484 | Intermediate Similarity | NPD2296 | Approved |
0.7483 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7483 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7471 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7471 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD4661 | Approved |
0.7468 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD4662 | Approved |
0.7464 | Intermediate Similarity | NPD1894 | Discontinued |
0.745 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7447 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7439 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7423 | Intermediate Similarity | NPD5711 | Approved |
0.7423 | Intermediate Similarity | NPD5710 | Approved |
0.7415 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD1613 | Approved |
0.7415 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7397 | Intermediate Similarity | NPD3764 | Approved |
0.7389 | Intermediate Similarity | NPD7458 | Discontinued |
0.7386 | Intermediate Similarity | NPD2354 | Approved |
0.7386 | Intermediate Similarity | NPD3887 | Approved |
0.7379 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7376 | Intermediate Similarity | NPD1535 | Discovery |
0.7365 | Intermediate Similarity | NPD6355 | Discontinued |
0.7358 | Intermediate Similarity | NPD6279 | Approved |
0.7358 | Intermediate Similarity | NPD6844 | Discontinued |
0.7358 | Intermediate Similarity | NPD6280 | Approved |
0.7357 | Intermediate Similarity | NPD17 | Approved |
0.7351 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7349 | Intermediate Similarity | NPD3751 | Discontinued |
0.7347 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7343 | Intermediate Similarity | NPD1876 | Approved |
0.7338 | Intermediate Similarity | NPD7440 | Discontinued |
0.7329 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7329 | Intermediate Similarity | NPD4625 | Phase 3 |
0.731 | Intermediate Similarity | NPD9494 | Approved |
0.731 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD5889 | Approved |
0.7296 | Intermediate Similarity | NPD5890 | Approved |
0.7292 | Intermediate Similarity | NPD1470 | Approved |
0.7292 | Intermediate Similarity | NPD1164 | Approved |
0.729 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7284 | Intermediate Similarity | NPD6971 | Discontinued |
0.7283 | Intermediate Similarity | NPD4287 | Approved |
0.7278 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4749 | Approved |
0.726 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7255 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7254 | Intermediate Similarity | NPD1201 | Approved |
0.725 | Intermediate Similarity | NPD7577 | Discontinued |
0.7246 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7239 | Intermediate Similarity | NPD74 | Approved |
0.7239 | Intermediate Similarity | NPD9266 | Approved |
0.7237 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD2353 | Approved |
0.7234 | Intermediate Similarity | NPD1778 | Approved |
0.723 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7229 | Intermediate Similarity | NPD2403 | Approved |
0.7212 | Intermediate Similarity | NPD3787 | Discontinued |
0.7212 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7212 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7208 | Intermediate Similarity | NPD7003 | Approved |
0.72 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7197 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7192 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7179 | Intermediate Similarity | NPD7212 | Phase 2 |
PubChem CID   | 5879763 |
ChEMBL   | CHEMBL460400 |
ZINC   |
Molecular Weight:   | 324.14 |
ALogP:   | 0.5904 |
MLogP:   | 3.22 |
XLogP:   | 4.484 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 66.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 24 |